IP Library Granted Patent US 9,946,844
Granted Patent B2
US 9,946,844 · App. 15/060,514 · Granted Apr 17, 2018

Systems and methods for monitoring patient medication adherence

Inventors: Robert Kaul (Brooklyn, NY); Sara Ross-Howe (Campbellville, CA); Justin Pedro (Waterloo, CA)
Assignee: CLOUD DX, INC.
G06F19/3456A61B5/0205A61B5/0225A61B5/02055A61B5/14551A61B5/4833G16H10/60A61B5/0022A61B5/02125A61B5/0404A61B5/6822A61B5/6826A61B5/7435A61B2560/0468
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,946,844
App. No.
15/060,514
Granted
Apr 17, 2018
Kind
B2
Abstract

Invention for determining a patient's adherence to various prescribed medications. Here a variety of different types of patient pulse wave measurements (blood pressure, pulse oximeter, ECG) and other physiological measurements are obtained. This actual data is compared to calculated measurements that would be expected based on the various patient baseline measurements in the absence of medication, schedule of medications, and impact of medications the various patient baseline measurements. If the actual data meets expectations, then the patient is likely adhering to the regime. Depending on which types of data do not meet expectations, non-adherence to various previously described medications may be reported. Other types of patient physiological readings, such as temperature, motion, lung function, brain wave function (EEG) and the like may also be obtained, and these additional types of readings can be used to extend the range of different types of drugs/medications that the invention can successfully monitor.

Claims (32)

1. A method for determining a patient's adherence to a mix of medications in a medication regimen, said method comprising:

providing patient operable instrumentation comprising:

a plurality of physiological monitoring devices configured to obtain a plurality of different types of actual patient pulse wave measurements comprising electrode-based time varying electrocardiograph readings, and time varying blood oxygen saturation levels, and time varying blood pressure measurements;

at least one processor configured to control the plurality of physiological monitoring devices and memory;

wherein said patient operable instrumentation and said physiological monitoring devices are a unitized, common processor controlled, system including;

wherein said time varying blood pressure measurement types are oscillometric cuff type blood pressure measurements;

obtaining a plurality of medication impact parameters, each individual medication impact parameter providing information on how a specific medication alters a specific type of pulse wave measurements, the plurality of medication impact parameters including medication impact parameters for each medication in the mix;

obtaining a plurality of patient reference information, each individual patient reference information providing information on a specific type of patient baseline pulse wave measurement in an absence of patient medication;

wherein said plurality of medication impact parameters and plurality of patient reference information further provide information corresponding to all of said different types of actual patient pulse wave measurements;

obtaining dosing schedule information for the mix of medications of the medication regimen;

storing the plurality of medication impact parameters, the plurality of patient reference information, and the dosing schedule information in said memory;

obtaining said plurality of different types of actual patient pulse wave measurements with the patient operable instrumentation;

analyzing, using said at least one processor, said plurality of different types of actual patient pulse wave measurements;

calculating, using said at least one processor, expected patient pulse wave measurements, corresponding to all of the different types of actual patient pulse wave measurements, based on the mix of medications, said dosing schedule information and said plurality of patient reference information and said plurality of medication impact parameters;

identifying which one or more medications from the mix of medications in the regimen was not taken by the patient, based on determining, using said at least one processor, which of said plurality of different types of actual patient pulse wave measurements are inconsistent with said expected patient pulse wave measurements; and

issuing an alarm reporting the one or more medications not taken by the patient.

2. The method of claim 1 , further obtaining patient alarm information, said patient alarm information reporting on any of the blood oxygen saturation, blood pressure measurements, or electrocardiograph readings that fall outside of previously established boundaries.

3. The method of claim 1 , further determining with said processor when inconsistent findings were obtained over more than one different type of actual patient pulse wave measurements.

4. The method of claim 1 , wherein determining said plurality of medication impact parameters by said processor by from at least one of either:

a) averages over a plurality of other patients in a presence and absence of said a medication from the mix of medications, further computing difference parameters between said presence and absence of said a medication from the mix of medications;

b) data obtained from said patient in said presence and absence of said a medication from the mix of medications, further computing difference parameters between said presence and absence of said a medication from the mix of medications.

5. The method of claim 1 , wherein said plurality of patient reference information by said processor from at least one of either:

a) averages over a plurality of other patients in an absence of said a medication from the mix of medications;

b) data obtained from said patient in said absence of said a medication from the mix of medications.

6. The method of claim 1 , wherein the determining said expected patient pulse wave measurements by said processor, includes:

for each individual medication in said patient medication schedule information;

a) using selected corresponding individual medication impact parameters from said plurality of medication impact parameters to produce selected individual medication impact parameters;

b) applying, either analytically or empirically, said selected individual medication impact parameters to said plurality of patient reference information to produce intermediate transformed patient reference information;

c) producing said expected patient pulse wave measurements by repeating steps a and b until all individual medication in said mix information has been processed.

7. The method of claim 1 , wherein said patient operable instrumentation is further configured to receive compliance information from said patient reporting on periods of at least one of patient medication compliance or non-compliance, and to use said compliance information to select at least some actual patient pulse wave measurements for use in establishing or refining at least some of said medication impact parameters or said patient reference information.

8. The method of claim 1 , further reporting at least some of those medications where inconsistent findings were determined by said processor to a remote computerized device over a network; and storing least some of those medication where inconsistent findings were obtained in at least one remote network computer memory.

9. The method of claim 1 wherein any of said plurality of medication impact parameters, plurality of patient reference information, and dosing schedule information is either uploaded or downloaded by said processor over a network from a remote computerized device.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded May 28, 2026
From: 1493907 B.C. LTD
To: VITALITI TECHNOLOGIES INC.
Reel/Frame 074782/0741 →
NUNC PRO TUNC ASSIGNMENT Recorded May 26, 2026
From: CLOUD DX, INC., A CORPORATION OF DELAWARE
To: 1493907 B.C. LTD
Reel/Frame 074758/0089 →
SECURITY INTEREST Recorded Apr 12, 2018
From: CLOUD DX, INC.
To: KAYBEE NEUTRAL, INC.
Reel/Frame 045523/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: KAUL, ROBERT; ROSS-HOWE, SARA; PEDRO, JUSTIN
To: CLOUD DX, INC., A CORPORATION OF DELAWARE
Reel/Frame 037888/0656 →
Continuity (4)
Continuation In Part 14186151 · Feb 21, 2014
Provisional Application 61767839 · Feb 22, 2013
Provisional Application 62138377 · Mar 25, 2015
Related Publication 20160188839A1 · Jun 30, 2016